FDA Brief

Company record

Intas Pharmaceuticals Limited

3 FDA warning letters since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Intas Pharmaceuticals Limited.

Warning letters

  1. Intas Pharmaceuticals Limited

    FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.

    High risk
  2. Intas Pharmaceuticals Limited

    CGMP/Finished Pharmaceuticals/Adulterated

  3. Intas Pharmaceuticals Limited

    CGMP/Finished Pharmaceuticals/Adulterated